NCT05001347 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05001347
Title	A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ) in Patients With Ovarian Cancer and Selected Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	I-Mab Biopharma US Limited
Indications	fallopian tube cancer ovarian cancer triple-receptor negative breast cancer head and neck squamous cell carcinoma gastric adenocarcinoma lung non-small cell carcinoma gastroesophageal adenocarcinoma ovary epithelial cancer
Therapies	Uliledlimab
Age Groups:	senior \| adult
Covered Countries	USA

NCT05001347
Clinical Trial Detail